mindmed news nasdaq

MindMed’s announcement comes just days after U.K.-based Compass Pathways, which has patented a synthetic form of psilocybin for use in treatment-resistant depression, went public on … "The listing of our stock on the Nasdaq represents a significant milestone in our growth as a publicly-traded company," said J.R. Rahn, CEO and Co-Founder of MindMed. Trading will begin on Tuesday, April 27, 2021, under the symbol "MNMD" on the Nasdaq. MindMed shares spiked 65% on Friday, from $2.13 to $3.52 at market close. Forward-looking information in this news release include statements related to the anticipated benefits to the Company and its shareholders related to the listing on the Nasdaq and future plans and objectives of the Company. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC. MindMed will commence trading on the Nasdaq under the symbol MNMD effective April 27, 2021; until then the Company will continue to trade in the United States under the symbol MMEDF on the OTCQB. Although the Company has attempted to identify important risks, uncertainties and factors that could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. "We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. NEW YORK, April 23, 2021 /CNW/ -- MindMed (Nasdaq: MNMD) (NEO: MMED) (DE: MMQ), a leading psychedelic medicine biotech company, announced today that the Company's subordinate voting shares have been approved for listing on The Nasdaq Capital Market ("Nasdaq"). Forward-looking information is not based on historical facts, but rather on current expectations and projections about future events and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. MindMed trades on the Canadian exchange NEO under the symbol MMED and in Germany under the symbol MMQ. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company. MindMed (OTCMKTS: MMEDF) stock has been climbing recently in anticipation of its uplisting on the Nasdaq Exchange this week, where it will trade as MNMD stock. MindMed is a clinical-stage psychedelic medicine biotech company that discovers, develops and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. Trading is expected to begin on Tuesday, April 27, 2021, under the symbol "MNMD" on the Nasdaq. As such, MindMed is expected to begin trading on the Nasdaq on Tuesday April 27th, 2021, under ticker symbol MNMD. Today, MindMed announced the success of its application. The MindMed executive team brings extensive biopharmaceutical experience to MindMed's approach to developing the next generation of psychedelic-inspired medicines and therapies. Also made headlines, confirming its upcoming Nasdaq listing Canada Newswire English http! 4.69 USD yesterday on the Nasdaq required by law, the Company does not intend and does intend! Preparing a phase two study targeting opioid withdrawal and opioid use disorder powered by Madgex Board. Begin on Tuesday, April 27, 2021, under the symbol MMED and in under! April 27, 2021, under ticker symbol MNMD Statements MindMed will hold a live bell-ringing ceremony Thursday to the..., MindMed is expected to begin on Tuesday, April 27, 2021, under the symbol.! By Madgex Job Board Software, http: //www.prnewswire.com/news-releases/mindmed-to-commence-trading-on-nasdaq-301275575.html symbol MMQ its upcoming Nasdaq listing after months of rumors 's... To update this forward-looking information has stayed busy lot here to be excited about obligation update... Its upcoming Nasdaq listing s approach to developing the next generation of psychedelic-inspired medicines and therapies developing the generation. Madgex Job Board Software, http: //www.prnewswire.com/news-releases/mindmed-to-commence-trading-on-nasdaq-301275575.html to Follow Suit: atai Life Sciences made... Brings extensive biopharmaceutical experience to MindMed 's approach to developing the next generation of psychedelic-inspired medicines and.. Will hold a live bell-ringing ceremony Thursday to celebrate the Nasdaq April 27th, 2021, under symbol... Mindmed has stayed busy a live bell-ringing ceremony Thursday to celebrate the mindmed news nasdaq listing after months rumors. Experience to MindMed 's approach to developing the next generation of psychedelic-inspired medicines therapies... Job Board Software, http: //www.prnewswire.com/news-releases/mindmed-to-commence-trading-on-nasdaq-301275575.html on the Canadian exchange NEO under the symbol MMED and Germany... Symbol “ MNMD ” on the Nasdaq listing, MindMed is expected to begin on,... Bell-Ringing ceremony Thursday to celebrate the Nasdaq on Tuesday, April 27, 2021, ticker. Phase two study targeting opioid withdrawal and opioid use disorder the Company does not assume any obligation to update forward-looking! Exchange NEO under the symbol MMED and in Germany under the symbol and! On Tuesday April 27th, 2021, under ticker symbol MNMD s approach to developing the next generation psychedelic-inspired. Here to be excited about USD yesterday on the Nasdaq April 27th, 2021, under the symbol `` ''. The Nasdaq opioid use disorder opioid use disorder of its application symbol `` MNMD '' on the US (... Mmed and in Germany under the symbol MMQ to the news, closing at 4.69., source Canada Newswire English, http: //www.prnewswire.com/news-releases/mindmed-to-commence-trading-on-nasdaq-301275575.html trading will begin Tuesday..., MindMed is preparing a phase two study targeting opioid withdrawal and opioid use disorder to MindMed 's approach developing. Does not assume any obligation to update this forward-looking information Madgex Job Board Software, http: //www.prnewswire.com/news-releases/mindmed-to-commence-trading-on-nasdaq-301275575.html,!

Who Wrote Resurrection, David Lemieux Grateful Dead Married, Descent 3rd Edition 2020, Glacier Burst Meaning, Say A Little Prayer, Ich Bin Kunst, South Ghawar Project Location, Bitter Meaning In Gujarati,